Results 61 to 70 of about 8,362 (250)
Australasian Journal of Dermatology, EarlyView.ABSTRACT Generalised Granuloma Annulare (GGA) is a chronic inflammatory skin disorder with no standard treatment. Since the last review in 2013, new treatments and varied responses have highlighted the need for an updated synthesis to guide clinical decisions.
Luca Bettolini +11 more
wiley +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
Journal of the European Academy of Dermatology and Venereology, EarlyView.The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg +31 more
wiley +1 more source
Klinikai tapasztalataink cutan mastocytosisban. [PDF]
, 2013 Introduction: Mastocytosis is a clonal mast cell proliferative disease, devided into cutaneous and systemic forms. The characteristic symptoms are caused by neoplastic mast cell infiltrations in different organs and/or the release of mediators.
Csomor, Judit +7 more
core +1 more source
Polo‐like kinases and UV‐induced skin carcinogenesis: What we know and what's next
Photochemistry and Photobiology, EarlyView.The polo‐like kinase (PLK) family plays distinct and critical roles in the regulation of cell cycle progression, and its dysregulation has been implicated in various cancers. Ultraviolet (UV) radiation is a well‐established environmental factor in the development of skin cancer.
Tanya Jaiswal +3 more
wiley +1 more source
Tracing the Photoaddition of Pharmaceutical Psoralens to DNA
Molecules, 2020 The psoralens 8-methoxypsoralen (8-MOP), 4,5′,8-trimethylpsoralen (TMP) and 5-methoxypsoralen (5-MOP) find clinical application in PUVA (psoralen + UVA) therapy. PUVA treats skin diseases like psoriasis and atopic eczema.
Janina Diekmann +3 more
doaj +1 more source
Regression of psoriasis in HIV patient after antiretroviral therapy [PDF]
, 2003 Immunodeficiency syndrome was first described as a new disease in 1981 because an unusual association of Kaposi's Sarcoma and Pneumocystis carinii pneumonia in men. The skin is a frequent site of diseases due to this infection.
Almeida, José Roberto Paes De +3 more
core +4 more sources
Blocking or enhancing effects of some basic emollients in UVA penetration [PDF]
Anais Brasileiros de Dermatologia, 2018 : Background: Topical agents used in combination with phototherapy or photochemotherapy may have both blocking or enhancing effects in ultraviolet rays.
Sevgi Akarsu +3 more
doaj +1 more source
The Risk of Cancer Associated with Immunosuppressive Therapy for Skin Diseases [PDF]
, 2006 The possible carcinogenic risk of immunosuppressive therapies is an important issue in everyday clinical practise. Carcinogenesis is a slow multi step procedure, thus a long latency period is needed before cancer develops.
Väkevä, Liisa
core
Methoxsalen-induced macular toxicity
Indian Journal of Ophthalmology, 2017 Psoralen compounds such as methoxsalen are photosensitizer agents used in conjunction with ultraviolet A (UVA) radiation exposure as photochemotherapy (Psoralens and ultraviolet-A therapy [PUVA therapy]) for certain epidermal skin disorders such as ...
Aditya Maitray, Pukhraj Rishi
doaj +1 more source
Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
JEADV Clinical Practice, Volume 4, Issue 2, Page 503-506, June 2025.Abstract Mycosis fungoides (MF) is the most common cutaneous T cell lymphoma. Since 2018, mogamulizumab, an antibody directed to to the chemokine receptor CCR4, is licensed for the treatment of MF. Treatment with mogamulizumab is associated with the precipiation of different types of skin rashes summarized as mogamulizumab‐associated rash.
Lukas D. Uleer +6 more
wiley +1 more source